It is a bisphosphonate that can increase bone strength and reduce fractures in the hip, spine, wrist, arm, leg, or rib. The most common side effects include bone pain, nausea, and vomiting. People whose kidneys don’t work very well should avoid it or use it with caution.
Raloxifene belongs to a class of drugs called selective estrogen receptor modulators (SERMs). It is FDA-approved for the prevention and treatment of osteoporosis in postmenopausal women and to reduce risk of invasive breast cancer in postmenopausal women at high risk or with osteoporosis.
Reclast (zoledronic acid) is a prescription drug used to treat osteoporosis in men, postmenopausal women, and Paget's disease. Reclast also is used to prevent osteoporosis. Side effects, drug interactions, dosage, and pregnancy and breastfeeding safety information are provided.